Cargando…

Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy

BACKGROUND: Inflammatory bowel disease (IBD) is a complex disease with variable presentation, progression, and response to therapies. Current disease classification is based on subjective clinical phenotypes. The peripheral blood immunophenome can reflect local inflammation, and thus we measured 39...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosoy, Roman, Kim-Schulze, Seunghee, Rahman, Adeeb, Friedman, Joshua R., Huang, Ruiqi, Peters, Lauren A., Amir, El-ad, Perrigoue, Jacqueline, Stojmirovic, Aleksandar, Song, Won-min, Ke, Hao, Ungaro, Ryan, Mehandru, Saurabh, Cho, Judy, Dubinsky, Marla, Curran, Mark, Brodmerkel, Carrie, Schadt, Eric E., Sands, Bruce E., Colombel, Jean-Frederic, Kasarskis, Andrew, Argmann, Carmen A., Suárez-Fariñas, Mayte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263768/ https://www.ncbi.nlm.nih.gov/pubmed/33813036 http://dx.doi.org/10.1016/j.jcmgh.2021.03.012

Ejemplares similares

Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related Disease
por: Suárez-Fariñas, Mayte, et al.
Publicado: (2021)

Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association Loci
por: Di Narzo, Antonio F, et al.
Publicado: (2016)

High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors
por: Di Narzo, Antonio F., et al.
Publicado: (2017)

A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses
por: Comella, Phillip H., et al.
Publicado: (2021)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases
por: Michlmayr, Daniela, et al.
Publicado: (2018)

High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
por: Di Narzo, Antonio F, et al.
Publicado: (2019)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
por: Click, Benjamin, et al.
Publicado: (2022)

Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD
por: Click, Benjamin, et al.
Publicado: (2021)

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
por: Suárez-Fariñas, Mayte, et al.
Publicado: (2012)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

A functional genomics predictive network model identifies regulators of inflammatory bowel disease
por: Peters, Lauren A, et al.
Publicado: (2017)

Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
por: Tian, Suyan, et al.
Publicado: (2012)

Managing IBD in the COVID-19 era
por: Scalzo, Nicholas, et al.
Publicado: (2023)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
por: Sperger, John, et al.
Publicado: (2021)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
por: Sperger, John, et al.
Publicado: (2021)

Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021)

Gut microbiota density influences host physiology and is shaped by host and microbial factors
por: Contijoch, Eduardo J, et al.
Publicado: (2019)

Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications
por: Kim, Jaehwan, et al.
Publicado: (2015)

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis
por: Jha, Divya, et al.
Publicado: (2023)

The day after COVID-19 in IBD: how to go back to ‘normal’
por: Danese, Silvio, et al.
Publicado: (2020)

A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients
por: Peters, Lauren A., et al.
Publicado: (2023)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping
por: Cutler, David J., et al.
Publicado: (2015)

Multi-TGDR: A Regularization Method for Multi-Class Classification in Microarray Experiments
por: Tian, Suyan, et al.
Publicado: (2013)

Zebrafish model for IBD
Publicado: (2011)

IBD considerations in spondyloarthritis
por: Di Jiang, Caroline, et al.
Publicado: (2020)

Medical management of chronic pouch inflammation
por: Kayal, Maia, et al.
Publicado: (2022)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

Risk of Adverse Pregnancy Outcomes for Women with IBD in an Expert IBD Antenatal Clinic
por: Lever, Gillian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_liq5d9plsvfhmfei1v9154otoq